JB Chemicals and Pharmaceuticals Ltd posted a 21.6% year-on-year (YoY) growth in net profit for the third quarter of FY25 at ₹162.5 crore, against ₹133.6 crore in the year-ago period.
JB Chemicals and Pharmaceuticals Ltd’s revenue from operations increased by 14.1%, reaching ₹963.5 crore from ₹844.5 crore in Q3 FY24. EBITDA at the operating level jumped 14.1% to ₹254.5 crore from ₹223.1 crore in the same quarter last year. EBITDA margin was flat at 26.4%, indicating stable operational dynamics. Earnings Before Interest, Tax, Depreciation, and Amortization (EBITDA) is an important metric to evaluate profitability and business performance.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
